✦ LIBER ✦

Eliciting Preferences for Prioritizing Treatment of Rare Diseases: the Role of Opportunity Costs and Framing Effects

✍ Scribed by Desser, Arna S.; Olsen, Jan Abel; Grepperud, Sverre

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is subtotal thyroidectomy a cost-effecti

✍ Zanocco, Kyle; Heller, Michael; Elaraj, Dina; Sturgeon, Cord 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 484 KB

Cost-effectiveness analysis of the medic

✍ Kyle A. Zanocco; Cord Sturgeon; Peter Angelos 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 48 KB

PCV47 DECISION ANALYSIS ON EFFECTIVENESS

✍ A Goehler; R Dietz; KJ Osterziel; U Siebert 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Costs, Benefits, and Effectiveness of In

✍ Mendis, Shanthi; Chestnov, Oleg 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 327 KB

A Markov Model of the Cost Effectiveness

✍ Stephanie Kirbach, Kit Simpson, Paul J. Nietert, Jacobo Mintzer 📂 Article 📅 2008 🏛 Springer International Publishing AG 🌐 English ⚖ 129 KB

Expanding screening for rare metabolic d

✍ Ilona Autti-Rämö; Marjukka Måkelå; Harri Sintonen; Hanna Koskinen; Liisa Laajala 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB